A detailed history of Cambiar Investors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cambiar Investors LLC holds 981,585 shares of BMY stock, worth $56.3 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
981,585
Previous 785,724 24.93%
Holding current value
$56.3 Million
Previous $32.6 Million 55.67%
% of portfolio
2.06%
Previous 1.31%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$39.66 - $51.75 $7.77 Million - $10.1 Million
195,861 Added 24.93%
981,585 $50.8 Million
Q2 2024

Jul 26, 2024

BUY
$40.25 - $52.99 $707,675 - $931,670
17,582 Added 2.29%
785,724 $32.6 Million
Q1 2024

May 02, 2024

SELL
$47.98 - $54.4 $1.86 Million - $2.1 Million
-38,670 Reduced 4.79%
768,142 $41.7 Million
Q4 2023

Jan 25, 2024

BUY
$48.48 - $57.85 $3.31 Million - $3.95 Million
68,299 Added 9.25%
806,812 $41.4 Million
Q3 2023

Oct 30, 2023

BUY
$57.89 - $64.73 $5.75 Million - $6.43 Million
99,262 Added 15.53%
738,513 $42.9 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $40.7 Million - $45.2 Million
639,251 New
639,251 $40.9 Million
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $51 Million - $56.1 Million
-701,850 Closed
0 $0
Q1 2022

Apr 28, 2022

SELL
$61.48 - $73.72 $851,805 - $1.02 Million
-13,855 Reduced 1.94%
701,850 $51.3 Million
Q4 2021

Jan 27, 2022

SELL
$53.63 - $62.52 $815,980 - $951,241
-15,215 Reduced 2.08%
715,705 $44.6 Million
Q3 2021

Oct 22, 2021

SELL
$59.17 - $69.31 $37,099 - $43,457
-627 Reduced 0.09%
730,920 $43.2 Million
Q2 2021

Aug 02, 2021

BUY
$61.91 - $67.42 $3.72 Million - $4.05 Million
60,019 Added 8.94%
731,547 $48.9 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $3.41 Million - $3.84 Million
57,516 Added 9.37%
671,528 $42.4 Million
Q4 2020

Feb 03, 2021

BUY
$57.74 - $65.43 $12.3 Million - $13.9 Million
213,177 Added 53.18%
614,012 $38.1 Million
Q3 2020

Oct 21, 2020

BUY
$57.43 - $63.64 $23 Million - $25.5 Million
400,835 New
400,835 $24.2 Million
Q3 2018

Oct 25, 2018

SELL
$55.19 - $62.25 $30.9 Million - $34.9 Million
-560,751 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$50.53 - $62.98 $39,615 - $49,376
784 Added 0.14%
560,751 $31 Million
Q1 2018

Apr 26, 2018

SELL
$59.92 - $68.98 $7.46 Million - $8.59 Million
-124,498 Reduced 18.19%
559,967 $35.4 Million
Q4 2017

Jan 30, 2018

SELL
$59.94 - $65.35 $2.96 Million - $3.23 Million
-49,425 Reduced 6.73%
684,465 $41.9 Million
Q3 2017

Nov 06, 2017

BUY
$55.23 - $63.74 $40.5 Million - $46.8 Million
733,890
733,890 $46.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cambiar Investors LLC Portfolio

Follow Cambiar Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.